Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response. 2011

Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
Molecular Genetics Laboratory, Institute for Ophthalmic Research, Centre for Ophthalmology, University Clinics Tübingen, Germany. wissinger@uni-tuebingen.de

Cone dystrophy with supernormal rod response (CDSRR) is considered to be a very rare autosomal recessive retinal disorder. CDSRR is associated with mutations in KCNV2, a gene that encodes a modulatory subunit (Kv8.2) of a voltage-gated potassium channel. In this study, we found that KCNV2 mutations are present in a substantial fraction (2.2-4.3%) of a sample of 367 independent patients with a variety of initial clinical diagnoses of cone malfunction, indicating that CDSRR is underdiagnosed and more common than previously thought. In total, we identified 20 different KCNV2 mutations; 15 of them are novel. A new finding of this study is the substantial proportion of large deletions at the KCNV2 locus that accounts for 15.5% of the mutant alleles in our sample. We determined the breakpoints and size of all five different deletions, which ranged between 10.9 and 236.8 kb. Two deletions encompass the entire KCNV2 gene and one also includes the adjacent VLDLR gene. Furthermore, we investigated N-terminal amino acid substitution mutations for its effect on interaction with Kv2.1 using yeast two-hybrid technology. We found that these mutations dramatically reduce or abolish this interaction suggesting a lack of assembly of heteromeric Kv channels as one underlying pathomechanism of CDSRR.

UI MeSH Term Description Entries
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012174 Retinitis Pigmentosa Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina. Pigmentary Retinopathy,Tapetoretinal Degeneration,Pigmentary Retinopathies,Retinopathies, Pigmentary,Retinopathy, Pigmentary,Tapetoretinal Degenerations
D017384 Sequence Deletion Deletion of sequences of nucleic acids from the genetic material of an individual. Deletion Mutation,Deletion Mutations,Deletion, Sequence,Deletions, Sequence,Mutation, Deletion,Mutations, Deletion,Sequence Deletions
D019943 Amino Acid Substitution The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties. Amino Acid Substitutions,Substitution, Amino Acid,Substitutions, Amino Acid
D020798 Two-Hybrid System Techniques Screening techniques first developed in yeast to identify genes encoding interacting proteins. Variations are used to evaluate interplay between proteins and other molecules. Two-hybrid techniques refer to analysis for protein-protein interactions, one-hybrid for DNA-protein interactions, three-hybrid interactions for RNA-protein interactions or ligand-based interactions. Reverse n-hybrid techniques refer to analysis for mutations or other small molecules that dissociate known interactions. One-Hybrid System Techniques,Reverse One-Hybrid System Techniques,Reverse Two-Hybrid System Techniques,Three-Hybrid System Techniques,Yeast Two-Hybrid Assay,Yeast Two-Hybrid System Techniques,One-Hybrid System Technics,Reverse Three-Hybrid System Techniques,Three-Hybrid System Technics,Tri-Hybrid System Techniques,Two-Hybrid Assay,Two-Hybrid Method,Two-Hybrid System Technics,Yeast One-Hybrid System Techniques,Yeast Three-Hybrid Assay,Yeast Three-Hybrid System,Yeast Three-Hybrid System Techniques,Yeast Two-Hybrid System,n-Hybrid System Techniques,Assay, Two-Hybrid,Assay, Yeast Three-Hybrid,Assay, Yeast Two-Hybrid,Assays, Two-Hybrid,Assays, Yeast Three-Hybrid,Assays, Yeast Two-Hybrid,Method, Two-Hybrid,Methods, Two-Hybrid,One Hybrid System Technics,One Hybrid System Techniques,One-Hybrid System Technic,One-Hybrid System Technique,Reverse One Hybrid System Techniques,Reverse Three Hybrid System Techniques,Reverse Two Hybrid System Techniques,System Technique, n-Hybrid,System Techniques, n-Hybrid,System, Yeast Three-Hybrid,System, Yeast Two-Hybrid,Systems, Yeast Three-Hybrid,Systems, Yeast Two-Hybrid,Technic, One-Hybrid System,Technic, Three-Hybrid System,Technic, Two-Hybrid System,Technics, One-Hybrid System,Technics, Three-Hybrid System,Technics, Two-Hybrid System,Technique, One-Hybrid System,Technique, Three-Hybrid System,Technique, Tri-Hybrid System,Technique, Two-Hybrid System,Technique, n-Hybrid System,Techniques, One-Hybrid System,Techniques, Three-Hybrid System,Techniques, Tri-Hybrid System,Techniques, Two-Hybrid System,Techniques, n-Hybrid System,Three Hybrid System Technics,Three Hybrid System Techniques,Three-Hybrid Assay, Yeast,Three-Hybrid Assays, Yeast,Three-Hybrid System Technic,Three-Hybrid System Technique,Three-Hybrid System, Yeast,Three-Hybrid Systems, Yeast,Tri Hybrid System Techniques,Tri-Hybrid System Technique,Two Hybrid Assay,Two Hybrid Method,Two Hybrid System Technics,Two Hybrid System Techniques,Two-Hybrid Assay, Yeast,Two-Hybrid Assays,Two-Hybrid Assays, Yeast,Two-Hybrid Methods,Two-Hybrid System Technic,Two-Hybrid System Technique,Two-Hybrid System, Yeast,Two-Hybrid Systems, Yeast,Yeast One Hybrid System Techniques,Yeast Three Hybrid Assay,Yeast Three Hybrid System,Yeast Three Hybrid System Techniques,Yeast Three-Hybrid Assays,Yeast Three-Hybrid Systems,Yeast Two Hybrid Assay,Yeast Two Hybrid System,Yeast Two Hybrid System Techniques,Yeast Two-Hybrid Assays,Yeast Two-Hybrid Systems,n Hybrid System Techniques,n-Hybrid System Technique
D024642 Potassium Channels, Voltage-Gated Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the ACTION POTENTIAL. Voltage-Gated Potassium Channels,Kv Potassium Channels,Potassium Channel, Voltage-Gated,Voltage-Gated K+ Channels,Voltage-Gated Potassium Channel,K+ Channels, Voltage-Gated,Potassium Channel, Voltage Gated,Potassium Channels, Kv,Potassium Channels, Voltage Gated,Voltage Gated K+ Channels,Voltage Gated Potassium Channel,Voltage Gated Potassium Channels

Related Publications

Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
January 2022, European journal of ophthalmology,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
June 2008, American journal of ophthalmology,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
February 2008, Investigative ophthalmology & visual science,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
November 2013, Ophthalmology,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
September 2007, Ophthalmic genetics,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
June 2019, Documenta ophthalmologica. Advances in ophthalmology,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
August 2021, Ophthalmic genetics,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
May 2022, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
January 2013, Investigative ophthalmology & visual science,
Bernd Wissinger, and Simone Schaich, and Britta Baumann, and Michael Bonin, and Herbert Jägle, and Christoph Friedburg, and Balázs Varsányi, and Carel B Hoyng, and Hélène Dollfus, and John R Heckenlively, and Thomas Rosenberg, and Günter Rudolph, and Ulrich Kellner, and Roberto Salati, and Astrid Plomp, and Elfride De Baere, and Monika Andrassi-Darida, and Alexandra Sauer, and Christiane Wolf, and Ditta Zobor, and Antje Bernd, and Bart P Leroy, and Péter Enyedi, and Frans P M Cremers, and Birgit Lorenz, and Eberhart Zrenner, and Susanne Kohl
October 2021, Molecular genetics & genomic medicine,
Copied contents to your clipboard!